| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 606.21B | 586.66B | 522.43B | 547.15B | 501.51B | 507.13B |
| Gross Profit | 82.15B | 76.80B | 65.58B | 57.32B | 62.68B | 64.89B |
| EBITDA | 40.82B | 35.57B | 25.38B | 20.77B | 29.25B | 31.62B |
| Net Income | 25.01B | 25.19B | 16.10B | 11.00B | 18.56B | 19.73B |
Balance Sheet | ||||||
| Total Assets | 890.18B | 923.57B | 872.06B | 815.56B | 761.20B | 735.79B |
| Cash, Cash Equivalents and Short-Term Investments | 80.17B | 89.17B | 114.41B | 97.54B | 130.84B | 105.14B |
| Total Debt | 244.66B | 256.28B | 226.91B | 211.75B | 179.48B | 151.13B |
| Total Liabilities | 541.03B | 570.37B | 516.53B | 492.29B | 442.15B | 423.25B |
| Stockholders Equity | 338.05B | 342.23B | 348.52B | 317.25B | 316.57B | 310.02B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -36.38B | 6.95B | -67.11B | 3.99B | -48.62B |
| Operating Cash Flow | 0.00 | 26.41B | 62.15B | -30.84B | 27.27B | -21.14B |
| Investing Cash Flow | 0.00 | -61.19B | -48.85B | -26.10B | -20.43B | -30.85B |
| Financing Cash Flow | 0.00 | 7.36B | 1.03B | 22.53B | 18.31B | 31.28B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥346.38B | 11.11 | 16.55% | 4.26% | 9.49% | 64.79% | |
75 Outperform | ¥2.68T | 10.54 | 14.23% | 2.47% | 2.27% | 70.36% | |
74 Outperform | ¥274.28B | 9.47 | 7.62% | 3.44% | 7.54% | 115.47% | |
71 Outperform | ¥2.95T | 15.14 | 13.56% | 1.96% | 10.52% | 71.09% | |
70 Outperform | ¥457.90B | 6.11 | ― | 2.73% | 18.92% | 73.08% | |
64 Neutral | ¥501.88B | 9.14 | 10.95% | 1.88% | 16.67% | 5.82% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |